Annual Drug Patent Expirations for CLENPIQ
Clenpiq is a drug marketed by Ferring Pharms Inc and is included in one NDA. It is available from one supplier. There are two patents protecting this drug and one Paragraph IV challenge.
Drug patent litigation for CLENPIQ.
This drug has twelve patent family members in nine countries.
The generic ingredient in CLENPIQ is citric acid; magnesium oxide; sodium picosulfate. One supplier is listed for this compound. Additional details are available on the citric acid; magnesium oxide; sodium picosulfate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com